ORX:STO
Orexo AB
1,06 SEK
arrow_upward
+0,95%(+0,0100) 1D
10 қар., 12:46:04 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,06 SEK
High
1,15 SEK
Low
0,91 SEK
Mkt. cap
37,11 млн
Avg. vol.
582,45 м.
Volume
773,12 м.
P/E ratio
0,05
52-wk high
22,55 SEK
52-wk low
0,81 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,06 SEK
High
1,15 SEK
Low
0,91 SEK
Mkt. cap
37,11 млн
Avg. vol.
582,45 м.
Volume
773,12 м.
P/E ratio
0,05
52-wk high
22,55 SEK
52-wk low
0,81 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
BigGo Finance
·
20 минут бұрын
Value Funds Outrun the S&P 500 as AI Sell-Off Hits Tech-Heavy Benchmarks
Yahoo Finance
·
49 минут бұрын
State Street SPDR Portfolio S&P 500 ETF (SPYM) Adds Apple and Nvidia on Nov. 6
AOL.com
·
42 минут бұрын
This Vanguard ETF Has Outperformed the S&P 500 and Nasdaq Composite
FXStreet
·
3 сағат бұрын
S&P 500: Tech rebound drives strong gains – Deutsche Bank
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com